KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Accounts Payables (2016 - 2025)

Jazz Pharmaceuticals has reported Accounts Payables over the past 16 years, most recently at $122.1 million for Q4 2025.

  • Quarterly Accounts Payables rose 56.75% to $122.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $122.1 million through Dec 2025, up 56.75% year-over-year, with the annual reading at $122.1 million for FY2025, 56.75% up from the prior year.
  • Accounts Payables was $122.1 million for Q4 2025 at Jazz Pharmaceuticals, down from $152.2 million in the prior quarter.
  • Over five years, Accounts Payables peaked at $152.2 million in Q3 2025 and troughed at $63.8 million in Q3 2021.
  • The 5-year median for Accounts Payables is $93.3 million (2022), against an average of $94.2 million.
  • Biggest five-year swings in Accounts Payables: surged 272.23% in 2021 and later crashed 35.45% in 2024.
  • Tracing JAZZ's Accounts Payables over 5 years: stood at $100.3 million in 2021, then fell by 9.51% to $90.8 million in 2022, then rose by 13.21% to $102.8 million in 2023, then dropped by 24.22% to $77.9 million in 2024, then soared by 56.75% to $122.1 million in 2025.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $122.1 million, $152.2 million, and $89.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.